Pediatric Health Care Products and Services Market

Pediatric Health Care Products and Services Market (Service: Child Psychiatry Services, Gastrointestinal Services, Pediatric Cancer Services, Pediatric Diabetes Services, Pediatric Heart Services, Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Market Outlook 2031

  • The global pediatric health care products and services market size stood at US$ 95.6 Bn in 2022
  • It is expected to increase at a CAGR of 6.9% from 2023 to 2031 and reach US$ 173.5 Bn by the end of 2031

Analyst Viewpoint

Rise in number of children with disorders and diseases, such as allergies, asthma and other respiratory disorders, high blood pressure, obesity, mental disorders, and infectious diseases, is driving the global pediatric health care products and services industry growth. Moreover, increase in awareness levels about pediatric health and rise in number of programs targeted toward safeguarding the interests and rights of the children are anticipated to propel the demand for pediatric products and services in the next few year.

Government programs and initiatives that promote comprehensive development in children are expected to help improve the overall well-being of children and boost the pediatric health care products and services market during the forecast period. Furthermore, increase in demand for pediatric healthcare across the globe is expected to create opportunities for leading pharmaceutical manufacturers to develop new treatments and technologies that can improve the health outcomes for children.

Pediatric Health Care Products And Services Market

Market Introduction

Increase in burden of diseases and disorders, such as infectious diseases, allergies, and other respiratory conditions, among children and rise in emphasis on newborn screening programs focused on detecting various health conditions in infants are expected to drive the pediatric health care products and services market value.

One of the prominent pediatric healthcare products and services market trends is the growing emphasis on funding, drug and device development, physician-scientist training, and diversity. Addressing early-life diseases and adverse childhood experiences has lifelong benefits for individuals, families, and communities. This may also limit or even prevent numerous chronic adult-onset diseases that originate in early life.

Significant increase in prevalence of disorders among neonates and babies is prompting major pharmaceutical companies to develop effective pediatric drugs and therapies. Moreover, surge in awareness and diagnosis of pediatric disorders is driving the number of children who require special care, which in turn is boosting the demand for child care services.

Rise in Incidence of Infectious Illnesses in Children Driving Pediatric health care products and services market Demand

Growing burden of diseases, viral infections, and malnutrition cases every year is a key factor boosting the pediatric healthcare products and services market demand. Additionally, rise in need for care for chronic illness, diarrhea, and injury-related sickness among children is boosting the demand for pediatric wellness solutions and children's healthcare services.

Technological advancements and a growing focus on preventive care are expected to fuel the pediatric healthcare products and services market revenue during the forecast period. Furthermore, surge in unhealthy lifestyle habits among children and rise in obese pediatric population is prompting leading drug manufacturers to focus on expanding their pediatric wellness offerings.

Increase in Expenditure on Pediatric Health Care Propelling Pediatric Health Care Products and Services Market Growth

In 2020, children accounted for approximately 23% of the U.S. population and about 10% of all public healthcare spending. Increase in funding for research on pediatric disorders, especially in countries such as the U.S., the U.K., and Germany, is expected to result in new treatment options for the management of various ailments in children.

Countries across the globe are partnering with the prominent players in the pharmaceutical industry to develop novel drugs that address concerns arising due to resistance developed by microorganisms toward antibiotic drugs. These initiatives are anticipated to boost investments for the development of new and improved medicines to be used for combating antibiotic-resistant bacteria.

Major pharmaceutical companies are focusing on new product launches along with expanding the indications of existing drugs for pediatric patients in order to tap into the large unmet needs. These factors are likely to positively impact the pediatric health care products and services market forecast during the forecast period.

Regional Pediatric Health Care Products and Services Market Outlook

North America accounted for a notable pediatric health care products and services market share in 2022 due to rise in government funding and growth in demand for pediatric healthcare services. Furthermore, the market in North America is estimated to grow considerably in the next few years due to rise in number of pediatric patients suffering from various health conditions such as autism, respiratory disorders, cerebral palsy, and muscular atrophy.

The pediatric health care products & services industry growth is Asia Pacific is anticipated to be rapid during the forecast period due to increase in number of awareness campaigns regarding pediatric ailments in countries such as India, China, and Philippines. Moreover, rise in spending on pediatric and public healthcare is crucial for the development of new treatments and technologies that can improve the health outcomes for children.

Analysis of Key Players

According to the latest pediatric health care products and services market analysis, prominent companies operating in the industry are offering a diverse product portfolio along with a strong global distribution system. Key players are also adopting the latest technologies to develop effective drugs and devices, which in turn is likely to strengthen their geographical reach and customer base.

AstraZeneca Plc, Boehringer Ingelheim Plc, Eisai Co., Ltd., Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Mylan N.V., Novartis AG, Pediapharm, Inc., Pfizer, Inc., and Sanofi S.A. are a few prominent entities operating in the global pediatric health care products and services market.

Key Developments

  • In April 2022, Pediatric Home Healthcare, LLC completed the acquisition of Vila Children Therapy to expand its reach at the national as well as international level
  • In April 2022, Gilead unveiled a pediatric drug development center in Ireland. It would be conducting pediatric clinical trials for seven products across 18 countries.
  • In February 2022, BioNTech and Pfizer, Inc, initiated rolling submission asking for amendment of the Emergency Use Authorization (EUA) of Pfizer-BioNTech Covid-19 Vaccine for including children aged between 6 months and 4 years
  • In December 2021, Sanofi announced the acquisition of Origimm Biotechnology GmbH with the objective of expanding its reach in the development of vaccine against acne

Pediatric Health Care Products and Services Market Snapshot

Attribute Detail
Size in 2022 US$ 95.6 Bn
Forecast (Value) in 2031 More than US$ 173.5 Bn
Growth Rate (CAGR) 6.9%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Drug Class
    • Antibiotics
    • Analgesics
    • Anti-asthmatics
    • Antidepressants
    • Antidiarrheal
    • Antifungal
    • Anti-histamines
    • Antihypertensives
    • Anti-metabolites
    • Anti-neoplastic antibiotics
    • Antiphychotics
    • Others
  • Disease/Disorder
    • Allergy and Respiratory
    • Cancer
    • Cardiovascular
    • Central Nervous System
    • Gastrointestinal
    • Hormonal Imbalance
    • Infections
    • Others
  • Service
    • Child Psychiatry Services
    • Gastrointestinal Services
    • Pediatric Cancer Services
    • Pediatric Diabetes Services
    • Pediatric Heart Services
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
Companies Profiled
  • AstraZeneca Plc
  • Boehringer Ingelheim Plc
  • Eisai Co., Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pediapharm, Inc.
  • Pfizer, Inc.
  • Sanofi S.A.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the pediatric health care products and services market in 2022?

The global market was valued at US$ 95.6 Bn in 2022

How is the pediatric health care products and services business expected to grow during the forecast period?

It is projected to grow at a CAGR of 6.9% from 2023 to 2031

What are the key factors driving demand for pediatric health care products and services?

Rise in incidence of infectious illnesses in children and increase in expenditure on pediatric healthcare

Which pediatric health care products and services segment held largest share in 2022?

The allergy and respiratory disorders segment accounted for the largest share in 2022

Which region is expected to dominate the pediatric health care products and services industry during the forecast period?

North America is likely to be a dominant region in the next few years.

Who are the key players in pediatric health care products and services sector?

AstraZeneca plc, Boehringer Ingelheim plc, Eisai Co., Ltd., Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Mylan N.V., Novartis AG, Pediapharm, Inc., Pfizer, Inc., and Sanofi S.A.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Pediatric Health Care Products and Services Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Pediatric Health Care Products and Services Market Analysis and Forecast, 2023-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Disease/Disorder/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Pediatric Health Care Products and Services Market Analysis and Forecast, by Disease/Disorder

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Disease/Disorder, 2023–2031

            6.3.1. Allergy and Respiratory

            6.3.2. Cancer

            6.3.3. Cardiovascular

            6.3.4. Central Nervous System

            6.3.5. Gastrointestinal

            6.3.6. Hormonal Imbalance

            6.3.7. Infections

            6.3.8. Others

        6.4. Market Attractiveness, by Disease/Disorder

    7. Global Pediatric Health Care Products and Services Market Analysis and Forecast, by Drug Class

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Drug Class, 2023–2031

            7.3.1. Antibiotics

            7.3.2. Analgesics

            7.3.3. Anti-asthmatics

            7.3.4. Antidepressants

            7.3.5. Antidiarrheal

            7.3.6. Antifungal

            7.3.7. Anti-histamines

            7.3.8. Antihypertensives

            7.3.9. Anti-metabolites

            7.3.10. Anti-neoplastic Antibiotics

            7.3.11. Antipsychotics

            7.3.12. Others

            7.3.13. Market Attractiveness, by Drug Class

    8. Global Pediatric Health Care Products and Services Market Analysis and Forecast, by Service

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Service, 2023–2031

            8.3.1. Child Psychiatry Services

            8.3.2. Gastrointestinal Services

            8.3.3. Pediatric Cancer Services

            8.3.4. Pediatric Diabetes Services

            8.3.5. Pediatric Heart Services

            8.3.6. Others

        8.4. Market Attractiveness, by Service

    9. Global Pediatric Health Care Products and Services Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2023–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness, by Region

    10. North America Pediatric Health Care Products and Services Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Disease/Disorder, 2023–2031

            10.2.1. Allergy and Respiratory

            10.2.2. Cancer

            10.2.3. Cardiovascular

            10.2.4. Central Nervous System

            10.2.5. Gastrointestinal

            10.2.6. Hormonal Imbalance

            10.2.7. Infections

            10.2.8. Others

        10.3. Market Attractiveness, by Disease/Disorder

        10.4. Market Value Forecast, by Drug Class, 2023–2031

            10.4.1. Antibiotics

            10.4.2. Analgesics

            10.4.3. Anti-asthmatics

            10.4.4. Antidepressants

            10.4.5. Antidiarrheal

            10.4.6. Antifungal

            10.4.7. Anti-histamines

            10.4.8. Antihypertensives

            10.4.9. Anti-metabolites

            10.4.10. Anti-neoplastic Antibiotics

            10.4.11. Antipsychotics

            10.4.12. Others

        10.5. Market Attractiveness, by Drug Class

        10.6. Market Value Forecast, by Service, 2023–2031

            10.6.1. Child Psychiatry Services

            10.6.2. Gastrointestinal Services

            10.6.3. Pediatric Cancer Services

            10.6.4. Pediatric Diabetes Services

            10.6.5. Pediatric Heart Services

            10.6.6. Others

        10.7. Market Attractiveness, by Service

        10.8. Market Value Forecast, by Country, 2023–2031

            10.8.1. U.S.

            10.8.2. Canada

        10.9. Market Attractiveness Analysis

            10.9.1. By Disease/Disorder

            10.9.2. By Drug Class

            10.9.3. By Service

            10.9.4. By Country

    11. Europe Pediatric Health Care Products and Services Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Disease/Disorder, 2023–2031

            11.2.1. Allergy and Respiratory

            11.2.2. Cancer

            11.2.3. Cardiovascular

            11.2.4. Central Nervous System

            11.2.5. Gastrointestinal

            11.2.6. Hormonal Imbalance

            11.2.7. Infections

            11.2.8. Others

        11.3. Market Attractiveness, by Disease/Disorder

        11.4. Market Value Forecast, by Drug Class, 2023–2031

            11.4.1. Antibiotics

            11.4.2. Analgesics

            11.4.3. Anti-asthmatics

            11.4.4. Antidepressants

            11.4.5. Antidiarrheal

            11.4.6. Antifungal

            11.4.7. Anti-histamines

            11.4.8. Antihypertensives

            11.4.9. Anti-metabolites

            11.4.10. Anti-neoplastic Antibiotics

            11.4.11. Antipsychotics

            11.4.12. Others

        11.5. Market Attractiveness, by Drug Class

        11.6. Market Value Forecast, by Service, 2023–2031

            11.6.1. Child Psychiatry Services

            11.6.2. Gastrointestinal Services

            11.6.3. Pediatric Cancer Services

            11.6.4. Pediatric Diabetes Services

            11.6.5. Pediatric Heart Services

            11.6.6. Others

        11.7. Market Attractiveness, by Service

        11.8. Market Value Forecast, by Country/Sub-region, 2023–2031

            11.8.1. Germany

            11.8.2. U.K.

            11.8.3. France

            11.8.4. Italy

            11.8.5. Spain

            11.8.6. Rest of Europe

        11.9. Market Attractiveness Analysis

            11.9.1. By Disease/Disorder

            11.9.2. By Drug Class

            11.9.3. By Service

            11.9.4. By Country/Sub-region

    12. Asia Pacific Pediatric Health Care Products and Services Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Disease/Disorder, 2023–2031

            12.2.1. Allergy and Respiratory

            12.2.2. Cancer

            12.2.3. Cardiovascular

            12.2.4. Central Nervous System

            12.2.5. Gastrointestinal

            12.2.6. Hormonal Imbalance

            12.2.7. Infections

            12.2.8. Others

        12.3. Market Attractiveness, by Disease/Disorder

        12.4. Market Value Forecast, by Drug Class, 2023–2031

            12.4.1. Antibiotics

            12.4.2. Analgesics

            12.4.3. Anti-asthmatics

            12.4.4. Antidepressants

            12.4.5. Antidiarrheal

            12.4.6. Antifungal

            12.4.7. Anti-histamines

            12.4.8. Antihypertensives

            12.4.9. Anti-metabolites

            12.4.10. Anti-neoplastic Antibiotics

            12.4.11. Antipsychotics

            12.4.12. Others

        12.5. Market Attractiveness, by Drug Class

        12.6. Market Value Forecast, by Service, 2023–2031

            12.6.1. Child Psychiatry Services

            12.6.2. Gastrointestinal Services

            12.6.3. Pediatric Cancer Services

            12.6.4. Pediatric Diabetes Services

            12.6.5. Pediatric Heart Services

            12.6.6. Others

        12.7. Market Attractiveness, by Service

        12.8. Market Value Forecast, by Country/Sub-region, 2023–2031

            12.8.1. China

            12.8.2. Japan

            12.8.3. India

            12.8.4. Australia & New Zealand

            12.8.5. Rest of Asia Pacific

        12.9. Market Attractiveness Analysis

            12.9.1. By Disease/Disorder

            12.9.2. By Drug Class

            12.9.3. By Service

            12.9.4. By Country/Sub-region

    13. Latin America Pediatric Health Care Products and Services Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Disease/Disorder, 2023–2031

            13.2.1. Allergy and Respiratory

            13.2.2. Cancer

            13.2.3. Cardiovascular

            13.2.4. Central Nervous System

            13.2.5. Gastrointestinal

            13.2.6. Hormonal Imbalance

            13.2.7. Infections

            13.2.8. Others

        13.3. Market Attractiveness, by Disease/Disorder

        13.4. Market Value Forecast, by Drug Class, 2023–2031

            13.4.1. Antibiotics

            13.4.2. Analgesics

            13.4.3. Anti-asthmatics

            13.4.4. Antidepressants

            13.4.5. Antidiarrheal

            13.4.6. Antifungal

            13.4.7. Anti-histamines

            13.4.8. Antihypertensives

            13.4.9. Anti-metabolites

            13.4.10. Anti-neoplastic Antibiotics

            13.4.11. Antipsychotics

            13.4.12. Others

        13.5. Market Attractiveness, by Drug Class

        13.6. Market Value Forecast, by Service, 2023–2031

            13.6.1. Child Psychiatry Services

            13.6.2. Gastrointestinal Services

            13.6.3. Pediatric Cancer Services

            13.6.4. Pediatric Diabetes Services

            13.6.5. Pediatric Heart Services

            13.6.6. Others

        13.7. Market Attractiveness, by Service

        13.8. Market Value Forecast, by Country/Sub-region, 2023–2031

            13.8.1. Brazil

            13.8.2. Mexico

            13.8.3. Rest of Latin America

        13.9. Market Attractiveness Analysis

            13.9.1. By Disease/Disorder

            13.9.2. By Drug Class

            13.9.3. By Service

            13.9.4. By Country/Sub-region

    14. Middle East & Africa Pediatric Health Care Products and Services Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Disease/Disorder, 2023–2031

            14.2.1. Allergy and Respiratory

            14.2.2. Cancer

            14.2.3. Cardiovascular

            14.2.4. Central Nervous System

            14.2.5. Gastrointestinal

            14.2.6. Hormonal Imbalance

            14.2.7. Infections

            14.2.8. Others

        14.3. Market Attractiveness, by Disease/Disorder

        14.4. Market Value Forecast, by Drug Class, 2023–2031

            14.4.1. Antibiotics

            14.4.2. Analgesics

            14.4.3. Anti-asthmatics

            14.4.4. Antidepressants

            14.4.5. Antidiarrheal

            14.4.6. Antifungal

            14.4.7. Anti-histamines

            14.4.8. Antihypertensives

            14.4.9. Anti-metabolites

            14.4.10. Anti-neoplastic Antibiotics

            14.4.11. Antipsychotics

            14.4.12. Others

        14.5. Market Attractiveness, by Drug Class

        14.6. Market Value Forecast, by Service, 2023–2031

            14.6.1. Child Psychiatry Services

            14.6.2. Gastrointestinal Services

            14.6.3. Pediatric Cancer Services

            14.6.4. Pediatric Diabetes Services

            14.6.5. Pediatric Heart Services

            14.6.6. Others

        14.7. Market Attractiveness, by Service

        14.8. Market Value Forecast, by Country/Sub-region, 2023–2031

            14.8.1. GCC Countries

            14.8.2. South Africa

            14.8.3. Rest of Middle East & Africa

        14.9. Market Attractiveness Analysis

            14.9.1. By Disease/Disorder

            14.9.2. By Drug Class

            14.9.3. By Service

            14.9.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player – Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. AstraZeneca plc

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Disease/Disorder Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. Boehringer Ingelheim GmbH

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Disease/Disorder Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. Eisai Co., Ltd.

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Disease/Disorder Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. Gilead Sciences, Inc.

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Disease/Disorder Portfolio

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. GlaxoSmithKline plc

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Disease/Disorder Portfolio

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

                15.3.5.5. Strategic Overview

            15.3.6. Merck & Co., Inc.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Disease/Disorder Portfolio

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

                15.3.6.5. Strategic Overview

            15.3.7. Mylan N.V.

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Disease/Disorder Portfolio

                15.3.7.3. Financial Overview

                15.3.7.4. SWOT Analysis

                15.3.7.5. Strategic Overview

            15.3.8. Novartis AG

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Disease/Disorder Portfolio

                15.3.8.3. Financial Overview

                15.3.8.4. SWOT Analysis

                15.3.8.5. Strategic Overview

            15.3.9. Pediapharm, Inc.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Disease/Disorder Portfolio

                15.3.9.3. Financial Overview

                15.3.9.4. SWOT Analysis

                15.3.9.5. Strategic Overview

            15.3.10. Pfizer, Inc.

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Disease/Disorder Portfolio

                15.3.10.3. Financial Overview

                15.3.10.4. SWOT Analysis

                15.3.10.5. Strategic Overview

            15.3.11. Sanofi S.A.

                15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.11.2. Disease/Disorder Portfolio

                15.3.11.3. Financial Overview

                15.3.11.4. SWOT Analysis

                15.3.11.5. Strategic Overview

    List of Tables

    Table 01: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023–2031

    Table 02: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023–2031

    Table 03: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023–2031

    Table 04: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Region, 2023–2031

    Table 05: North America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country, 2023–2031

    Table 06: North America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023–2031

    Table 07: North America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023–2031

    Table 08: North America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023–2031

    Table 09: Europe Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

    Table 10: Europe Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023–2031

    Table 11: Europe Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023–2031

    Table 12: Europe Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023–2031

    Table 13: Asia Pacific Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

    Table 14: Asia Pacific Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023–2031

    Table 15: Asia Pacific Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023–2031

    Table 16: Asia Pacific Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023–2031

    Table 17: Latin America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

    Table 18: Latin America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023–2031

    Table 19: Latin America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023–2031

    Table 20: Latin America Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023–2031

    Table 21: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

    Table 22: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disease/Disorder, 2023–2031

    Table 23: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2023–2031

    Table 24: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service, 2023–2031

    List of Figures

    Figure 01: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031

    Figure 02: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn), by Disease/Disorder, 2022

    Figure 03: Global Pediatric Health Care Products and Services Market Value Share, by Disease/Disorder, 2022

    Figure 04: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn), by Drug Class, 2022

    Figure 05: Global Pediatric Health Care Products and Services Market Value Share, by Drug Class, 2022

    Figure 06: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn), by Service, 2022

    Figure 07: Global Pediatric Health Care Products and Services Market Value Share, by Service, 2022

    Figure 08 Global Pediatric Health Care Products and Services Market Value Share, by Region, 2022

    Figure 09: Global Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast, 2023–2031

    Figure 10: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031

    Figure 11: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023-2031

    Figure 12: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031

    Figure 13: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023-2031

    Figure 14: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031

    Figure 15: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023-2031

    Figure 16: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Region, 2022 and 2031

    Figure 17: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Region, 2023-2031

    Figure 18: North America Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 19: North America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Pediatric Health Care Products and Services Market Value Share Analysis, by Country, 2022 and 2031

    Figure 21: North America Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031

    Figure 22: North America Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031

    Figure 23: North America Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031

    Figure 24: North America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023–2031

    Figure 25: North America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023–2031

    Figure 26: North America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023–2031

    Figure 27: Europe Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 28: Europe Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Pediatric Health Care Products and Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 30: Europe Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031

    Figure 31: Europe Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031

    Figure 32: Europe Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031

    Figure 33: Europe Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023–2031

    Figure 34: Europe Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023–2031

    Figure 35: Europe Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023–2031

    Figure 36: Asia Pacific Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 37: Asia Pacific Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Pediatric Health Care Products and Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 39: Asia Pacific Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031

    Figure 40: Asia Pacific Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031

    Figure 41: Asia Pacific Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031

    Figure 42: Asia Pacific Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2022–2031

    Figure 43: Asia Pacific Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023–2031

    Figure 44: Asia Pacific Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023–2031

    Figure 45: Latin America Pediatric Health Care Products and Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 46: Latin America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Pediatric Health Care Products and Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 48: Latin America Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031

    Figure 49: Latin America Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031

    Figure 50: Latin America Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031

    Figure 51: Latin America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023–2031

    Figure 52: Latin America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023–2031

    Figure 53: Latin America Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023–2031

    Figure 54: Middle East & Africa Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 55: Middle East & Africa Pediatric Health Care Products and Services Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Pediatric Health Care Products and Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 57: Middle East & Africa Pediatric Health Care Products and Services Market Value Share Analysis, by Disease/Disorder, 2022 and 2031

    Figure 58: Middle East & Africa Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2022 and 2031

    Figure 59: Middle East & Africa Pediatric Health Care Products and Services Market Value Share Analysis, by Service, 2022 and 2031

    Figure 60: Middle East & Africa Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disease/Disorder, 2023–2031

    Figure 61: Middle East & Africa Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class, 2023–2031

    Figure 62: Middle East & Africa Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved